Nathaniel Fleming, MD, MS
Assistant Professor
Neurology
School of Medicine

Publications (13)

Top publication keywords:
Multiple SclerosisReoperationWatchful WaitingSkin NeoplasmsPhysicians, Primary CareVeteransNeoplasm Recurrence, LocalDementiaDermatologic Surgical ProceduresMargins of ExcisionGeography, MedicalBiopsyMelanomaMicroRNAsDysplastic Nevus Syndrome

• Classification and Management of Ischemic Stroke in Patients With Active Cancer: A Scientific Statement From the American Heart Association.
  Stroke 2026 Navi BB, Kasner SE, Cushman M, Okwuosa TM, Fleming NH, Behr JM, Yang JJ, Gupta A, DeAngelis LM, American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing
• Risk of dementia in older veterans with multiple sclerosis.
  Multiple sclerosis and related disorders 2023 Fleming NH, Bahorik A, Xia F, Yaffe K
• TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors.
  The Journal of investigative dermatology 2020 Chang GA, Wiggins JM, Corless BC, Syeda MM, Tadepalli JS, Blake S, Fleming N, Darvishian F, Pavlick A, Berman R, Shapiro R, Shao Y, Karlin-Neumann G, Spittle C, Osman I, Polsky D
• Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study.
  Journal of the American Academy of Dermatology 2019 Fleming NH, Shaub AR, Bailey E, Swetter SM
• Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.
  JAMA dermatology 2018 Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, …

Show all (8 more) Hide

• Impact of primary care provider density on detection and diagnosis of cutaneous melanoma.
  PloS one 2018 Fleming NH, Grade MM, Bendavid E
• Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.
  JAMA dermatology 2016 Fleming NH, Egbert BM, Kim J, Swetter SM
• Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.
  Journal of medical genetics 2015 Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Krogsgaard M, Kirchhoff T
• Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Gumaste PV, Fleming NH, Silva I, Shapiro RL, Berman RS, Zhong J, Osman I, Stein JA
• Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
  Cancer 2014 Fleming NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, Brady B, Han SW, Hanniford D, Wang J, Shapiro RL, Hernando E, Osman I
• PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition.
  Molecular cancer research : MCR 2013 Gold HL, Wengrod J, de Miera EV, Wang D, Fleming N, Sikkema L, Kirchhoff T, Hochman T, Goldberg JD, Osman I, Gardner LB
• Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis.
  Melanoma research 2013 Qian M, Ma MW, Fleming NH, Lackaye DJ, Hernando E, Osman I, Shao Y
• Impact of age on the management of primary melanoma patients.
  Oncology 2013 Fleming NH, Tian J, Vega-Saenz de Miera E, Gold H, Darvishian F, Pavlick AC, Berman RS, Shapiro RL, Polsky D, Osman I